Identity or diagnosis?

Eighteen documents, no single case or bill, and the most contested question in the argument-tree series. The Cass Review, WPATH, the APA, the Endocrine Society, SEGM, WHO, a Supreme Court opinion, an executive order, and international sports bodies argue across six questions about how gender dysphoria and trans identity should be classified, treated, and governed. Hover a card to see the assumption underneath it, click it for the full exchange, and ask where the evidence itself, not just the advocacy, actually stands.

Question

Cautious/restrictive clinical and legal approach Gender-affirming clinical and legal approach Neutral or contested findings both sides invoke

Color marks the side of the volley, not who is right. K marks a source that is neutral either because it is an evidence-quality finding rather than a policy recommendation (the Cass Review's own stated rule, applied the same way regardless of which side a finding happens to help), or because no competing measurement of the same thing exists in this source set.

A caution before you count silences. Whether a side holds the last recorded word in a lane usually reflects which document happened to be published most recently, not which argument was stronger. In this dataset the cautious/restrictive side's core documents (the Cass Review, SEGM, the 2025 executive order and guidance) are the newest in the set, while the affirming side's core documents (APA, AAP, the Endocrine Society, WPATH, the IOC) mostly predate 2023. That timing gap, not argument quality, is the main reason recency-driven last words skew one direction in this topic, the fourth topic running in this series where that pattern recurs.